Research graph
References from A promising combination strategy: oncolytic adenovirus (ΔE1B-55 K/E3) and arsenic trioxide for potent cancer therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/nbt.2287
10.1038/nbt.2287 · 2012 · External reference
10.1111/cas.13027
10.1111/cas.13027 · 2016 · External reference
10.3389/fimmu.2022.1012806
10.3389/fimmu.2022.1012806 · 2022 · External reference
10.1080/2162402x.2018.1442169
10.1080/2162402x.2018.1442169 · External reference
10.2174/1568009618666171129221503
10.2174/1568009618666171129221503 · 2018 · External reference
10.1371/journal.ppat.1002853
10.1371/journal.ppat.1002853 · External reference
10.1038/ncponc0736
10.1038/ncponc0736 · 2007 · External reference
10.1038/sj.cgt.7700727
10.1038/sj.cgt.7700727 · 2004 · External reference
10.1080/21645515.2020.1723363
10.1080/21645515.2020.1723363 · 2020 · External reference
10.1001/jamaoncol.2016.2064
10.1001/jamaoncol.2016.2064 · 2017 · External reference
10.1038/nrd4663
10.1038/nrd4663 · 2015 · External reference
10.1002/cbin.11563
10.1002/cbin.11563 · 2021 · External reference
Unresolved reference
1999 · External reference
10.3390/cancers13143386
10.3390/cancers13143386 · 2021 · External reference
10.2147/ov.s66083
10.2147/ov.s66083 · External reference
10.3389/fonc.2022.940019
10.3389/fonc.2022.940019 · 2022 · External reference
10.3390/v15020547
10.3390/v15020547 · 2023 · External reference
10.3389/fonc.2017.00106
10.3389/fonc.2017.00106 · 2017 · External reference
10.1016/j.coviro.2016.06.009
10.1016/j.coviro.2016.06.009 · 2016 · External reference
10.1038/s41568-018-0009-4
10.1038/s41568-018-0009-4 · 2018 · External reference
10.5772/intechopen.1003010
10.5772/intechopen.1003010 · External reference
Unresolved reference
2004 · External reference
10.1038/s41423-022-00956-0
10.1038/s41423-022-00956-0 · 2023 · External reference
10.1128/jvi.72.12.9470-9478.1998
10.1128/jvi.72.12.9470-9478.1998 · 1998 · External reference
Unresolved reference
2002 · External reference
10.1016/j.ccr.2004.11.012
10.1016/j.ccr.2004.11.012 · 2004 · External reference
10.7150/jca.46463
10.7150/jca.46463 · 2020 · External reference
10.1586/erv.09.29
10.1586/erv.09.29 · 2009 · External reference
10.1006/smvy.1998.0156
10.1006/smvy.1998.0156 · External reference
10.1038/nbt887
10.1038/nbt887 · 2003 · External reference
10.1177/10430342251411042
10.1177/10430342251411042 · External reference
10.1038/nrc3770
10.1038/nrc3770 · 2014 · External reference
10.1038/s41573-019-0029-0
10.1038/s41573-019-0029-0 · 2019 · External reference
10.1038/sj.bjc.6604969
10.1038/sj.bjc.6604969 · 2009 · External reference
10.1007/s12011-022-03500-3
10.1007/s12011-022-03500-3 · 2023 · External reference
10.3389/fimmu.2023.1118246
10.3389/fimmu.2023.1118246 · 2023 · External reference
10.1007/s12272-023-01481-y
10.1007/s12272-023-01481-y · 2024 · External reference
10.1186/s11658-020-00236-7
10.1186/s11658-020-00236-7 · 2020 · External reference
10.3390/medsci12010001
10.3390/medsci12010001 · 2023 · External reference
10.3390/cancers13143482
10.3390/cancers13143482 · 2021 · External reference
10.1016/j.canlet.2009.04.035
10.1016/j.canlet.2009.04.035 · 2009 · External reference
10.1007/s13277-015-3040-z
10.1007/s13277-015-3040-z · 2015 · External reference
10.4161/cc.5.19.3263
10.4161/cc.5.19.3263 · 2006 · External reference
10.3390/biomedicines10030564
10.3390/biomedicines10030564 · 2022 · External reference
10.1007/s12094-019-02054-6
10.1007/s12094-019-02054-6 · 2019 · External reference
10.2174/156652312800099599
10.2174/156652312800099599 · 2012 · External reference
10.1016/j.omto.2018.01.003
10.1016/j.omto.2018.01.003 · 2018 · External reference
10.3389/fmolb.2022.1039324
10.3389/fmolb.2022.1039324 · 2022 · External reference
10.3390/v8060167
10.3390/v8060167 · 2016 · External reference
10.1371/journal.pone.0211192
10.1371/journal.pone.0211192 · 2019 · External reference
